Tregalizumab

DRUG2 trials

Sponsors

Biotest, T-Balance Therapeutics GmbH

Conditions

Allergic AsthmaAllergy to House Dust MiteRheumatoid Arthritis

Phase 2

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis

TerminatedNCT01999192

BiotestRheumatoid Arthritis

Start: 2013-10-31End: 2015-07-31Updated: 2017-08-24

Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients

CompletedNCT04673591

T-Balance Therapeutics GmbHAllergic Asthma, Allergy to House Dust Mite

Start: 2020-12-09End: 2022-01-12Updated: 2022-02-08

Related Papers

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.

2018-01-1712 citations